π° Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Unregulated sales of a toxic and hallucinogenic mushroom endanger public health
Americans' interest in a potentially harmful 'magic mushroom' is soaring, according to a new study. The scientists suggest that the growing market for Amanita muscaria may be sparked in part by emerging clinical resea...
New understanding of how antidepressants work
Researchers have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), reemphasizing their importance and aiming to reframe clinical conversation a...
Psychedelic drug-induced hyperconnectivity in the brain helps clarify altered subjective experiences
A new study shows that the use of psilocybin, a compound found in the widely known 'magic mushrooms,' initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and feelings of oceanic b...
How psychedelic drugs interact with serotonin receptors to potentially produce therapeutic benefits
Researchers have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatri...
'Mathematical microscope' reveals novel, energy-efficient mechanism of working memory that works even during sleep
Researchers have discovered a mechanism that creates memories while reducing metabolic cost, even during sleep. This efficient memory occurs in a part of the brain that is crucial for learning and memory, and where Al...
In psychedelic therapy, clinician-patient bond may matter most
Drug effects have dominated the national conversation about psychedelics for medical treatment, but a new study suggests that when it comes to reducing depression with psychedelic-assisted therapy, what matters most i...
General Volunteers
Volunteer with the Australian Psychedelic Society. Be a part of Australia's Psychedelic Story.
Protecting brain cells with cannabinol
Scientists created four cannabis-derived CBN analogs (chemical look-a-likes) with enhanced neuroprotective properties and potential for therapeutic application in neurological disorders like Alzheimer's, Parkinson's, ...
How to Choose a Psychedelic Support Person
In recent years we've observed various issues arising from the psychedelic underground and potential for issues in the emerging clinical frameworks. From safety concerns to ethical considerations, it's clear that p...
Researchers map how the brain regulates emotions
A new study is among the first of its kind to separate activity relating to emotion generation from emotion regulation in the human brain. The findings provide new insights that could help inform therapeutic treatment...
Crackdown on illicit drugs detects rise in 'designer' drug substitutes
As authorities crack down on illicit drugs, experts have issued an alert on the use of the synthetic stimulant pentylone, as new research finds a 75% increase in detections across Australia.
First Proof that Psilacetin is a Prodrug of Psilocin
Nichols and Frescasβ 1999 hypothesis becomes a validated scientific theory.
Delta-8-THC use reported by 11% of 12th graders in 2023
Approximately 11% of 12th-grade students across the United States reported past-year use of delta-8- tetrahydrocannabinol (delta-8-THC, or delta-8 for short), according to an analysis of data from the 2023 Monitoring ...
'Study drugs' set the stage for other drug use and mental health decline
Taking 'study drugs' like Adderall without a diagnosis is not only dangerous in itself, but can lead to other drug use and a decline in mental health, according to new research.